Regeneron Pharmaceuticals (REGN)
SG&A Expense Growth
2.22%
Quarterly · Period ending:
REGN SG&A Expense Growth
Latest reported2.22%period ending
Latest reported2.22%period ending
REGN Quarterly SG&A Growth (QoQ) (0.00% → 2.22%)
Latest values, visible window
High-resolution chart · PNG
REGN sg&a expense growth history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | SG&A Expense Growth |
|---|---|
| 17.3314% | |
| -34.6104% | |
| 78.814% | |
| 1.5196% | |
| -43.4567% | |
| 78% | |
| 6.25% | |
| 6.6667% | |
| -6.25% | |
| 14.2857% | |
| 7.6923% | |
| -23.5294% | |
| 21.4286% | |
| 16.6667% | |
| -14.2857% | |
| -17.6471% | |
| 13.3333% | |
| 7.1429% | |
| 0% | |
| -12.5% | |
| 6.6667% | |
| 25% | |
| -14.2857% | |
| -12.5% | |
| 0% | |
| -36% | |
| 25% | |
| -13.0435% | |
| 35.2941% | |
| -95.9233% | |
| 2,506.25% | |
| -84.6154% | |
| -1.8868% | |
| 35.8974% | |
| 4% | |
| 20.9677% | |
| -1.5873% | |
| 1,475% | |
| -77.7778% | |
| 200% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% |